文献库搜索 | GeneLibs

Narusawa(Y),Asaka(S),Muramoto(T),Konno(S),... Case Rep Pathol None

...PIK3CA H1047R (c.3140A > G) and CSF1R (c.∗1841TG > GA) in both the epithelial and mesenchymal components, indicating a c...

Gasparello(J),Angerilli(V),Rizzato(MD),Maf... Histopathology 2026-09-00

...PIK3CA (44%) and PTEN (24%) mutations, representing their most distinctive molecular feature. Overall, these findings su...

Wang(Y),Pan(D),Shao(T),Huang(X),Liang(Y),X... Curr Pharm Des 2026-05-25

...PIK3CA, STAT3). Enrichment analysis revealed that the biological processes primarily involved responses to xenobiotic st...

Galasso(I),Bayard(C),Blériot(C),Ladraa(S),... PNAS Nexus 2026-06-00

PIK3CA-related overgrowth spectrum (PROS) comprises a group of rare genetic disorders caused by de novo, mosaic, postzyg...

Ma(J),Ayres(CM),Brambley(CA),Eldaly(B),Per... Proc Natl Acad Sci U S A 2026-06-09

...PIK3CA oncogenic hotspot mutation restricted by HLA-A*03:01 were unable to recognize the same epitope in the context of ...

Zhang(M),Xie(B),Wu(L),Wu(X),Zhang(J),Shen(... Endocr Metab Immune Disord ... 2026-05-21

...PIK3CA, and ESR1. GO enrichment yielded 467 significant terms, while KEGG analysis identified 132 pathways, predominantl...

Pandey(SK),Arya(S),Mishra(A) Curr Mol Med 2026-05-20

...PIK3CA alterations converging to drive aggressive angiogenesis; (2) endothelial-specific dysregulation-TP53-driven disru...

Kohli(M),Shankar(A),Lloyd(J),Wang(L),Huo(X... JNCI Cancer Spectr 2026-05-09

...PIK3CA, PIK3CB, NOTCH1; losses: TMPRSS2, NCOR1, ZBTB18, TP53, NKX3-1) was used to develop an integrated clinico-genomic ...

Ramsheh(MY),Fraccari(RL),Christova(R),Kill... J Liq Biopsy 2026-06-00

...PIK3CA and TP53 was designed and optimised with commercially available reference material. Once sufficiently optimised, ...

Nofuji(K),Mariya(T),Kubo(T),Murota(A),Tera... Obstet Gynecol Int None

...PIK3CA mutations was identified as being potentially associated with adverse prognosis (hazard ratio: 2.73, 95% confiden...